Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial
CONCLUSION: The results of the present study do not support any positive effect of UA supplementation in improving echocardiographic and biochemical indices of HFrEF. Further studies with higher doses of UA and longer supplementation duration are encouraged to be conducted.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20210216050375N1.PMID:38415449 | DOI:10.2174/0115748871279354240209101604
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Tannaz Jamialahmadi Maede Hasanpour Farveh Vakilian Peter E Penson Milad Iranshahy Amirhossein Sahebkar Source Type: research
More News: Cancer & Oncology | Cardiology | Cholesterol | Clinical Trials | Heart | Heart Failure | Study